A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours-Reference-Cited by-同舟云学术

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours

Published:1993-01 Issue:16 Volume:29 Page:2225-2231
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bokemeyer C.,Schmoll H.-J.,Harstrick A.,Illiger H.J.,Metzner B.,Räth U.,Hohnloser J.,Clemm C.,Berdel W.,Siegert W.,Rüther U.,Ostermann H.,Kneba M.,Hartlapp J.H.,Schröder M.,Poliwoda H.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Treatment of testicular cancer: a new and improved model;Einhorn;J Clin Oncol,1990

2. Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide;Williams;N Engl J Med,1987

3. “Poor-risk” germ cell tumors: current progress and future directions;Motzer;Semin Oncol,1992

4. Dose-response and dose-survival advantage of high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer;Samson;Cancer,1984

5. A randomized trial of standard chemotherapy versus a high dose chemotherapy regimen in the treatment of poor prognosis;Ozols;J Clin Oncol,1988

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose chemotherapy for germ cell tumors: do we have a model?;Expert Opinion on Biological Therapy;2014-09-22

2. Stellenwert der Hochdosischemotherapie (HDCT) beim männlichen Keimzelltumor;Der Onkologe;2013-06-22

3. Hochdosischemotherapie und Residualtumorresektion bei Patienten mit Hodentumor;Der Urologe;2011-08-17

4. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974);Annals of Oncology;2011-05

5. Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group;Journal of Clinical Oncology;2003-11-15